SUBSCRIBERS
Hong Kong seeks to cash in on frenzy for Chinese biotech stocks
HK bourse is in the midst of weighing a proposal that would allow biotech firms to list before they turn a profit
Add BT as a preferred sourcePublished Mon, Jan 29, 2018 · 09:50 PM
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Hong Kong
CHINESE drug companies have been on a tear in the US stock market. Now, entrepreneurs and investors betting on the Asian country's fledgling biotechnology industry see another reason for optimism.
The stock exchange in Hong Kong - home to the world's fourth-largest equity market - is in the midst of weighing a proposal that would allow biotech companies to list even before they turn a profit.
Share with us your feedback on BT's products and services
